Kathmere Capital Management LLC Raises Holdings in CME Group Inc. $CME

06 Jul 2026, 10:25 by Kim Johansen · The Markets Daily

Kathmere Capital Management LLC boosted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 79.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,283 shares of the financial services provider’s stock after purchasing an additional 2,331 shares during the quarter. Kathmere Capital Management LLC’s holdings in CME Group were worth $1,560,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in CME Group during the fourth quarter worth about $1,523,241,000. Sanders Capital LLC purchased a new position in CME Group in the 3rd quarter worth approximately $1,006,932,000. Victory Capital Management Inc. lifted its stake in CME Group by 746.4% in the 4th quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock worth $559,720,000 after purchasing an additional 1,807,491 shares in the last quarter. Life Cycle Investment Partners Ltd acquired a new position in shares of CME Group during the 4th quarter worth approximately $217,656,000. Finally, Viking Global Investors LP acquired a new position in shares of CME Group during the 2nd quarter worth approximately $164,648,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

CME stock opened at $236.60 on Monday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The firm has a market cap of $85.73 billion, a PE ratio of 20.19, a PEG ratio of 2.65 and a beta of 0.25. The firm’s 50 day moving average price is $267.17 and its 200-day moving average price is $284.36. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period in the prior year, the business posted $2.80 earnings per share. On average, equities research analysts anticipate that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.2%. CME Group’s dividend payout ratio is currently 44.37%.

Insider Transactions at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CME shares. The Goldman Sachs Group cut their price target on CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Barclays lowered their price objective on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 23rd. Raymond James Financial restated an “outperform” rating and issued a $320.00 target price on shares of CME Group in a report on Thursday. UBS Group reaffirmed an “overweight” rating on shares of CME Group in a research note on Monday, June 15th. Finally, Morgan Stanley reduced their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a report on Thursday, April 23rd. Twelve analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, CME Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $300.94.

Read Our Latest Stock Report on CME

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.